- Home
- BNTX
BNTX
BioNTech SE
as 07-26-2024 4:00pm EST
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
| Founded: | 2008 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 19.3B | IPO Year: | 2019 |
| Target Price: | $111.70 | AVG Volume (30 days): | 518.8K |
| Analyst Decision: | Hold | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.51 | EPS Growth: | -98.10 |
| 52 Week Low/High: | $78.02 - $125.83 | Next Earning Date: | 08-05-2024 |
| Revenue: | $2,966,956,522 | Revenue Growth: | -77.65% |
| Revenue Growth (this year): | -27.21% | Revenue Growth (next year): | 0.61% |
Latest BioNTech SE News
BNTX Breaking Stock News: Dive into BNTX Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Pfizer, BioNTech Covid Vaccine Receives Approval in UK
Pharmaceutical Technology
3 days ago
Triastek and BioNTech to develop 3D-printed RNA therapeutics
GlobeNewswire
5 days ago
BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
MT Newswires
16 days ago
CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech
MT Newswires
24 days ago
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling
Pharmaceutical Technology
25 days ago
Lab to jab in 100 days: manufacturing flexibility for future rapid responses
Zacks
a month ago
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Pharmaceutical Technology
a month ago
CHMP recommends authorisation for Pfizer-BioNTech’s Covid-19 vaccine
Compare BNTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BNTX BioNTech SE - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.